The observed attenuation of hyperandrogenemia and PCOM by BHHF is consistent with emerging evidence suggesting that TCM can modulate GPR54/GnRH signaling via hypothalamic–pituitary–ovarian axis regulation [38]. The gene discussed is GNRH1; the disease is polycystic ovary syndrome.